Tag #Weight-Loss Medication

Showing 1 to 2 of 2 results

dw.com

🌐 85% Global Worthiness

Aug 1, 22:17

Counterfeit Weight-Loss Drugs Surge Amidst Soaring Demand

Soaring demand for weight-loss drugs like Wegovy and Ozempic has caused shortages and a surge in counterfeit medications, a global problem estimated by the WHO to affect one in ten drugs, with online pharmacies and compounding practices exacerbating the issue.

Counterfeit Weight-Loss Drugs Surge Amidst Soaring Demand

Soaring demand for weight-loss drugs like Wegovy and Ozempic has caused shortages and a surge in counterfeit medications, a global problem estimated by the WHO to affect one in ten drugs, with online pharmacies and compounding practices exacerbating the issue.

Progress

44% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How do unregulated online pharmacies and compounding practices contribute to the global problem of counterfeit drugs?

Increased demand, driven by the significant weight-loss effects of semaglutide and tirzepatide, has led to shortages and a rise in counterfeit drugs. Counterfeit drugs are sold online, through cross-border shopping, and organized criminal networks, often mimicking genuine products but containing incorrect ingredients or placebos. The lack of regulation surrounding compounding pharmacies, where approved drugs are reformulated, further exacerbates the problem.

nos.nl

🌐 85% Global Worthiness

Jan 27, 22:08

Soaring Demand for Expensive Weight-Loss Drugs in the Netherlands

The number of Dutch citizens purchasing costly new weight-loss drugs increased dramatically from 2000 prescriptions in 2022 to 109,000 in 2023, raising concerns about accessibility and the strain on the healthcare system due to high costs and potential exacerbation of health inequalities.

Soaring Demand for Expensive Weight-Loss Drugs in the Netherlands

The number of Dutch citizens purchasing costly new weight-loss drugs increased dramatically from 2000 prescriptions in 2022 to 109,000 in 2023, raising concerns about accessibility and the strain on the healthcare system due to high costs and potential exacerbation of health inequalities.

Progress

52% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How does the high cost of these medications contribute to existing health inequalities?

The surge in demand is driven by increased accessibility of Ozempic and similar medications, which suppress hunger. However, these drugs are expensive (Mounjaro costs €410 per month), unaffordable for many, exacerbating existing health inequalities. The high cost also raises concerns about the financial burden on the healthcare system if the government were to cover these treatments.

Showing 1 to 2 of 2 results